Medication info
Astatin 20 mg (Atorvastatin Calcium Trihydrate)

Astatin 20 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
Celix Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201701538 · Approved 2017.03.30 · Insurance code 646203890

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
Who uses it
Adults · Children
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during atorvastatin treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, for patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring an LDL cholesterol reduction of 45% or greater). This medicine is administered at a dosage of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol levels be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dosage of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients 70 years of age and older are similar to those in the general adult patient population.
Children's dosage
Ages 10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients).

Ingredients

Manufacturer
Celix Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps lower the risk of cardiovascular diseases. It can reduce the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and patients with type 2 diabetes. Additionally, it has effects in reducing risks associated with myocardial infarction, stroke, vascular surgeries, angina, and congestive heart failure. For hyperlipidemia patients, it plays a role in lowering total cholesterol and LDL cholesterol levels, while increasing HDL cholesterol. It is especially effective for patients with familial hypercholesterolemia and can be used in combination with other treatments, generally maintaining and improving cardiovascular health.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during atorvastatin treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, for patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring an LDL cholesterol reduction of 45% or greater). This medicine is administered at a dosage of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol levels be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dosage of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients 70 years of age and older are similar to those in the general adult patient population.

Children's dosage

Ages 10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients).

Precautions

This medication may cause severe adverse effects in the muscles, so if there is severe muscle pain or weakness, or if creatine kinase levels rise significantly, use should be discontinued immediately. Patients with liver dysfunction or very elevated liver enzyme levels should not use this medication and should undergo regular liver function tests. Women who are pregnant or may become pregnant, and breastfeeding women should not use this medication, and women of childbearing potential should use appropriate contraception. Children, especially those under 10 years old, should not use this medication, and children and adolescents over 10 years old should use it cautiously under medical guidance. This medication may interact with certain drugs, which can increase or decrease its blood concentration, so it is essential to inform your doctor or pharmacist if you are taking other medications. Particular care is needed when combined with potent CYP3A4 inhibitors or certain antibiotics, antifungals, and antivirals. Patients with a history of liver disease or those who consume excessive alcohol should use this medication cautiously, as the risk of myopathy may increase, necessitating careful monitoring for muscle symptoms. During treatment with this medication, if symptoms such as muscle pain, fatigue, or fever appear, you must inform healthcare professionals immediately for further examination. If severe rashes, blisters, itching, or angioedema occurs, discontinue use immediately. Elderly patients or patients with decreased kidney function are at higher risk of muscle adverse reactions, so dose adjustments and careful observation are necessary. In case of overdose, as there is no specific antidote, management should be based on symptoms and through liver function and blood tests. Store out of reach of children and keep in the original container to prevent deterioration in quality or misuse.

Side effects

  • Asthenia
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 170 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • oropharyngeal pain
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disorder
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications from rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urinary white blood cells
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function tests
  • gastritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • post-ictal phase
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbances
  • vertigo
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • reduced libido
  • affective disorder
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • tension hyperactivity
  • myositis
  • muscle diseases
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • contracture
  • elevated serum myoglobin
  • contact dermatitis
  • skin dryness
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequency of urination
  • cystitis
  • hematuria
  • dysuria
  • nephrolithiasis
  • nocturia
  • epididymitis
  • breast fibrocystic disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency of urination
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • lethargy
  • vasomotor edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive error
  • ocular hemorrhage
  • auditory loss
  • glaucoma
  • post-visual disturbances
  • taste loss
  • taste disturbances
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • increased ACTH
  • decreased aldosterone
  • elevated potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • increased AST

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it is best kept at room temperature between 1 to 30 degrees Celsius. Avoid keeping it in excessively hot or cold places.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.